26 results
8-K
EX-99.3
PRME
Prime Medicine, Inc.
30 Sep 24
Entry into a Material Definitive Agreement
7:38am
Meredith Goldwasser, Sc.D. SVP, Head of Strategy and Corporate Ops Richard Brudnick Chief Business Officer Niamh Alix Chief Human Resources Officer
PRE 14A
ldxvemxuymjihffee
19 Apr 24
Preliminary proxy
4:07pm
DEF 14A
ft87l
28 Apr 23
Definitive proxy
8:34am
10-Q
cve1joxx9fpq36s n4e2
14 Nov 22
Quarterly report
4:46pm
424B4
90azsbelgfff1g1saq
21 Oct 22
Prospectus supplement with pricing info
4:47pm
S-1/A
u29b3r hv68
13 Oct 22
IPO registration (amended)
10:51am
S-1
v8plu7ul9nxfb4quinv6
23 Sep 22
IPO registration
4:12pm
S-1
EX-10.4
tt6se0voxt999n1yh2a
23 Sep 22
IPO registration
4:12pm
DRS/A
nkpqsv 3d7uhu
5 Aug 22
Draft registration statement (amended)
12:00am
DRS/A
5s4yckz7q
6 May 22
Draft registration statement (amended)
12:00am